Inverness Medical Innovations, Inc., a world leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today reported its financial results for the quarter ended December 31, 2009.

It reported its fourth-quarter net loss available to stockholders to be $3.129 million compared to profit of $10.923 million the previous year. Loss per share was $0.04 compared to profit of $0.14 per share last year.

Its net revenue is revealed to be $546.2 million for the fourth quarter of 2009, compared to $432.5 million for the fourth quarter the previous year.

Reported revenues exclude revenues of $35.9 million for the fourth quarter of 2009 and $26.8 million for the fourth quarter of 2008 related to our Nutritionals business.

In addition, the loss per share from unceasing operations is revealed to be $0.08 compared to profit of $0.16 per share last year. Non-GAAP adjusted earnings per share increased to $0.71 from $0.66 prior year.

On average, 10 analysts polled by Thomson Reuters expected the company to report profit of $0.69 per share for the quarter.